ReviewFrontiers in immunology2023

Rituximab and improved nodular regenerative hyperplasia-associated non-cirrhotic liver disease in common variable immunodeficiency: a case report and literature study.

Willem Roosens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.